Formation of amyloid-like fibrils by Y-box binding protein 1 (YB-1) is mediated by its cold shock domain and modulated by disordered terminal domains

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Guryanov, Sergey G ^a   Selivanova, Olga M ^a   Nikulin, Alexey D ^a   Enin, Gennady A ^a   Melnik, Bogdan S ^a   Kretov, Dmitry A ^a   Serdyuk, Igor N ^a   Ovchinnikov, Lev P ^a  

^a INSTITUTE OF PROTEIN RESEARCH   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; Y BOX BINDING PROTEIN 1; RECOMBINANT PROTEIN; YBX1 PROTEIN, HUMAN;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; FIBER; IONIC STRENGTH; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; Y BOX BINDING PROTEIN 1 FIBRIL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; OSMOLARITY; PROTEIN TERTIARY STRUCTURE; X RAY DIFFRACTION;

AMYLOID; HUMANS; OSMOLAR CONCENTRATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; X-RAY DIFFRACTION; Y-BOX-BINDING PROTEIN 1;

EID: 84860671860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036969     Document Type: Article

References (56)

1. Chernov KG, Curmi PA, Hamon L, Mechulam A, Ovchinnikov LP, et al. (2008) Atomic force microscopy reveals binding of mRNA to microtubules mediated by two major mRNP proteins YB-1 and PABP. FEBS Lett 582: 2875-2881.
2. Chernov KG, Mechulam A, Popova NV, Pastre D, Nadezhdina ES, et al. (2008) YB-1 promotes microtubule assembly in vitro through interaction with tubulin and microtubules. BMC Biochem 9: 23.
3. Ruzanov PV, Evdokimova VM, Korneeva NL, Hershey JW, Ovchinnikov LP, (1999) Interaction of the universal mRNA-binding protein, p50, with actin: a possible link between mRNA and microfilaments. J Cell Sci 112 (Pt 20): 3487-3496.
4. Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D, (2006) The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 281: 29105-29119.
5. Yang WH, Bloch DB, (2007) Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 13: 704-712.
6. Davies AH, Barrett I, Pambid MR, Hu K, Stratford AL, et al. (2011) YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification. Oncogene 30: 3649-3660.
7. Janz M, Jürchott K, Karawajew L, Royer H, (2000) Y-box factor YB-1 is associated with the centrosome during mitosis. Gene Function & Disease 1: 57-59.
8. Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH, (1998) A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem 273: 32957-32965.
9. Norman JT, Lindahl GE, Shakib K, En-Nia A, Yilmaz E, et al. (2001) The Y-box binding protein YB-1 suppresses collagen α1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J Biol Chem 276: 29880-29890.
10. Evdokimova VM, Ovchinnikov LP, (1999) Translational regulation by Y-box transcription factor: involvement of the major mRNA-associated protein, p50. Int J Biochem Cell Biol 31: 139-149.
11. Skabkina OV, Lyabin DN, Skabkin MA, Ovchinnikov LP, (2005) YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining. Mol Cell Biol 25: 3317-3323.
12. Chansky HA, Hu M, Hickstein DD, Yang L, (2001) Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res 61: 3586-3590.
13. Dutertre M, Sanchez G, De Cian MC, Barbier J, Dardenne E, et al. (2010) Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol 17: 1358-1366.
14. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M, (2003) The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25: 691-698.
15. Bader AG, Felts KA, Jiang N, Chang HW, Vogt PK, (2003) Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway. Proc Natl Acad Sci U S A 100: 12384-12389.
16. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, et al. (2006) Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol 26: 277-292.
17. Bergmann S, Royer-Pokora B, Fietze E, Jürchott K, Hildebrandt B, et al. (2005) YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 65: 4078-4087.
18. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, et al. (2009) Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 15: 402-415.
19. Bargou RC, Jürchott K, Wagener C, Bergmann S, Metzner S, et al. (1997) Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3: 447-450.
20. Janz M, Harbeck N, Dettmar P, Berger U, Schmidt A, et al. (2002) Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer 97: 278-282.
21. Frye BC, Halfter S, Djudjaj S, Muehlenberg P, Weber S, et al. (2009) Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen. EMBO Rep 10: 783-789.
22. Rauen T, Raffetseder U, Frye BC, Djudjaj S, Mühlenberg PJ, et al. (2009) YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation. J Biol Chem 284: 26928-26940.
23. Eliseeva IA, Kim ER, Guryanov SG, Ovchinnikov LP, Lyabin DN, (2011) Y-box-binding protein 1 (YB-1) and its functions. Biochemistry (Mosc) 76: 1402-1433.
24. Kloks CP, Spronk CA, Lasonder E, Hoffmann A, Vuister GW, et al. (2002) The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1. J Mol Biol 316: 317-326.
25. Evdokimova VM, Wei CL, Sitikov AS, Simonenko PN, Lazarev OA, et al. (1995) The major protein of messenger ribonucleoprotein particles in somatic cells is a member of the Y-box binding transcription factor family. J Biol Chem 270: 3186-3192.
26. Skabkin MA, Kiselyova OI, Chernov KG, Sorokin AV, Dubrovin EV, et al. (2004) Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res 32: 5621-5635.
27. Selivanova OM, Guryanov SG, Enin GA, Skabkin MA, Ovchinnikov LP, et al. (2010) YB-1 is capable of forming extended nanofibrils. Biochemistry (Mosc) 75: 115-120.
28. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, et al. (2005) Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 12: 1-4.
29. Nelson R, Eisenberg D, (2006) Structural models of amyloid-like fibrils. Adv Protein Chem 73: 235-282.
30. Maury CP, (2009) The emerging concept of functional amyloid. J Intern Med 265: 329-334.
31. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, et al. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325: 328-332.
32. Lobanov MY, Galzitskaya OV, (2011) The Ising model for prediction of disordered residues from protein sequence alone. Phys Biol 8: 035004.
33. Sorokin AV, Selyutina AA, Skabkin MA, Guryanov SG, Nazimov IV, et al. (2005) Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response. EMBO J 24: 3602-3612.
34. Eanes ED, Glenner GG, (1968) X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 16: 673-677.
35. Kryndushkin DS, Alexandrov IM, Ter-Avanesyan MD, Kushnirov VV, (2003) Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 278: 49636-49643.
36. Chiti F, Dobson CM, (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366.
37. Nilsson MR, (2004) Techniques to study amyloid fibril formation in vitro. Methods 34: 151-160.
38. Klement K, Wieligmann K, Meinhardt J, Hortschansky P, Richter W, et al. (2007) Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's Aβ(1-40) amyloid fibrils. J Mol Biol 373: 1321-1333.
39. Munishkina LA, Henriques J, Uversky VN, Fink AL, (2004) Role of protein-water interactions and electrostatics in α-synuclein fibril formation. Biochemistry 43: 3289-3300.
40. Raman B, Chatani E, Kihara M, Ban T, Sakai M, et al. (2005) Critical balance of electrostatic and hydrophobic interactions is required for β2-microglobulin amyloid fibril growth and stability. Biochemistry 44: 1288-1299.
41. Alexandrescu AT, Rathgeb-Szabo K, (1999) An NMR investigation of solution aggregation reactions preceding the misassembly of acid-denatured cold shock protein A into fibrils. J Mol Biol 291: 1191-1206.
42. Max KE, Zeeb M, Bienert R, Balbach J, Heinemann U, (2007) Common mode of DNA binding to cold shock domains. Crystal structure of hexathymidine bound to the domain-swapped form of a major cold shock protein from Bacillus caldolyticus. FEBS J 274: 1265-1279.
43. Staniforth RA, Giannini S, Higgins LD, Conroy MJ, Hounslow AM, et al. (2001) Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J 20: 4774-4781.
44. Jaskólski M, (2001) 3D domain swapping, protein oligomerization, and amyloid formation. Acta Biochim Pol 48: 807-827.
45. Tafuri SR, Wolffe AP, (1992) DNA binding, multimerization, and transcription stimulation by the Xenopus Y box proteins in vitro. New Biol 4: 349-359.
46. Ozer J, Faber M, Chalkley R, Sealy L, (1990) Isolation and characterization of a cDNA clone for the CCAAT transcription factor EFIA reveals a novel structural motif. J Biol Chem 265: 22143-22152.
47. Baxa U, Taylor KL, Wall JS, Simon MN, Cheng N, et al. (2003) Architecture of Ure2p prion filaments: the N-terminal domains form a central core fiber. J Biol Chem 278: 43717-43727.
48. Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, et al. (2006) Functional amyloid formation within mammalian tissue. PLoS Biol 4: e6.
49. McGlinchey RP, Gruschus JM, Nagy A, Lee JC, (2011) Probing fibril dissolution of the repeat domain of a functional amyloid, Pmel17, on the microscopic and residue level. Biochemistry 50: 10567-10569.
50. Gonda K, Wudel J, Nelson D, Katoku-Kikyo N, Reed P, et al. (2006) Requirement of the protein B23 for nucleolar disassembly induced by the FRGY2a family proteins. J Biol Chem 281: 8153-8160.
51. Holm PS, Bergmann S, Jürchott K, Lage H, Brand K, et al. (2002) YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter. J Biol Chem 277: 10427-10434.
52. Flieger O, Engling A, Bucala R, Lue H, Nickel W, et al. (2003) Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett 551: 78-86.
53. Lashuel HA, Aljabari B, Sigurdsson EM, Metz CN, Leng L, et al. (2005) Amyloid fibril formation by macrophage migration inhibitory factor. Biochem Biophys Res Commun 338: 973-980.
54. Tacke F, Kanig N, En-Nia A, Kaehne T, Eberhardt CS, et al. (2011) Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease. BMC Cancer 11: 185.
55. Evdokimova VM, Kovrigina EA, Nashchekin DV, Davydova EK, Hershey JW, et al. (1998) The major core protein of messenger ribonucleoprotein particles (p50) promotes initiation of protein biosynthesis in vitro. J Biol Chem 273: 3574-35781.
56. Serpell LC, Fraser PE, Sunde M, (1999) X-ray fiber diffraction of amyloid fibrils. Methods Enzymol 309: 526-536.